Jodie Hay - Concepedia

Author

Jodie Hay

University of Glasgow ORCID

Also Known As

Hay, Jodie, J Hay, J. Hay, Jodie F Hay, Jodie F. Hay, Jodie Hay, Pamela Brereton, Phil Eeles

Publications

8.1K

Citations

H-Index

Concepts

All Affiliations

University of Glasgow University of Oxford University College London MRC Clinical Trials Unit at UCL Public Health England

About

Jodie Hay is an author at University of Glasgow specializing in medicine, virology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.1K
2	Epidemiology	5	5	1K
3	Public Health	3	3	311
4	Immunology	3	3	715
5	Cell Biology	1	1	13

Jodie Hay

Publications

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2020	5K
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley, The Lancet	2021	649
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, Nature Medicine VaccinationVaccine DevelopmentViral BurdenVaccine TargetCovid-19 Pandemic	2021	558
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey Koen B. Pouwels, Thomas House, Emma Pritchard, The Lancet Public Health Virus EpidemiologyEmerging Infectious DiseasesCovid-19 PandemicVirologyDisease Surveillance	2020	208
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, ImmunologyDelta VariantCovid-19Viral BurdenVaccine Effectiveness	2021	144
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time A. Sarah Walker, Emma Pritchard, Thomas House, eLife	2021	120
Increased infections, but not viral burden, with a new SARS-CoV-2 variant A. Sarah Walker, Karina-Doris Vihta, Owen Gethings, Growth RatesVirus EpidemiologyViral DiagnosticsCovid-19 EpidemiologyCycle Threshold	2021	67
Colonization of transplant unit water supplies with Legionella and protozoa: precautions required to reduce the risk of legionellosis W. J. Patterson, Jodie Hay, D.V. Seal, Journal of Hospital Infection Healthcare-associated InfectionMicrobiologyInfection ControlMedicineClinical Microbiology	1997	55
Efficacy of ChAdOx1 nCoV-19&nbsp;(AZD1222)&nbsp;Vaccine Against SARS-CoV-2 VOC&nbsp;202012/01&nbsp;(B.1.1.7) Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley, SSRN Electronic Journal	2021	51
Prognostic and therapeutic relevance of c‐<scp>FLIP</scp> in acute myeloid leukaemia Donal P. McLornan, Jodie Hay, Kirsty M. McLaughlin, British Journal of Haematology	2012	47

Page 1